Search

everythinglearnresearchcommunity

for

Search:↓

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Wasabi leaf extract affects gene expression in skin cells.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Different parts of the body have unique immune characteristics in their skin.

Activating TLR3 boosts autophagy gene expression in skin cells.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Targeting PTEN can improve healing in venous leg ulcers.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Transglutaminase 2 may control sebocyte maturation and lipid metabolism.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Bacteria can help skin regenerate through a process called IL-1β signaling.

RNase L suppresses regeneration in mammals.

Type I interferons play a key role in the development of various skin diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

EH-MSCs may help treat hair loss by reducing inflammation.